Acknowledgement
This work was supported by the Development of Platform Technology for Innovative Medical Measurement funded by Korea Research Institute of Standards and Science (KRISS-GP2022-0006), The Bio & Medical Technology Development Program of the National Research Foundation, MSIP (No. 2018M3D1A1058826), and the Seoul National University Hospital Research (No. 04-2019-0280).
References
- Abramson, D.H., Shields, C.L., Munier, F.L., and Chantada, G.L. (2015). Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 133, 1341-1347. https://doi.org/10.1001/jamaophthalmol.2015.3108
- Asada, N., Tsuchiya, H., Ueda, Y., and Tomita, K. (1998). Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line. Anticancer Res. 18(3A), 1765-1768.
- Behrens, B.C., Hamilton, T.C., Masuda, H., Grotzinger, K.R., Whang-Peng, J., Louie, K.G., Knutsen, T., McKoy, W.M., Young, R.C., and Ozols, R.F. (1987). Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 47, 414-418.
- Bond, W.S., Akinfenwa, P.Y., Perlaky, L., Hurwitz, M.Y., Hurwitz, R.L., and Chevez-Barrios, P. (2013). Tumorspheres but not adherent cells derived from retinoblastoma tumors are of malignant origin. PLoS One 8, e63519. https://doi.org/10.1371/journal.pone.0063519
- Chan, H.S., Lu, Y., Grogan, T.M., Haddad, G., Hipfner, D.R., Cole, S.P., Deeley, R.G., Ling, V., and Gallie, B.L. (1997). Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res. 57, 2325-2330.
- Chan, H.S., Thorner, P.S., Haddad, G., and Gallie, B.L. (1991). Multidrugresistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 98, 1425-1431. https://doi.org/10.1016/S0161-6420(91)32134-1
- Chen, S.Y., Hu, S.S., Dong, Q., Cai, J.X., Zhang, W.P., Sun, J.Y., Wang, T.T., Xie, J., He, H.R., Xing, J.F., et al. (2013). Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. Asian Pac. J. Cancer Prev. 14, 6135-6140. https://doi.org/10.7314/APJCP.2013.14.10.6135
- Cruet-Hennequart, S., Villalan, S., Kaczmarczyk, A., O'Meara, E., Sokol, A.M., and Carty, M.P. (2009). Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells. Cell Cycle 8, 3039-3050.
- Dallas, N.A., Xia, L., Fan, F., Gray, M.J., Gaur, P., van Buren, G., 2nd, Samuel, S., Kim, M.P., Lim, S.J., and Ellis, L.M. (2009). Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 69, 1951-1957. https://doi.org/10.1158/0008-5472.CAN-08-2023
- Glubrecht, D.D., Kim, J.H., Russell, L., Bamforth, J.S., and Godbout, R. (2009). Differential CRX and OTX2 expression in human retina and retinoblastoma. J. Neurochem. 111, 250-263. https://doi.org/10.1111/j.1471-4159.2009.06322.x
- Hou, Y., Zhu, Q., Li, Z., Peng, Y., Yu, X., Yuan, B., Liu, Y., Liu, Y., Yin, L., Peng, Y., et al. (2017). The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells. Cell Death Dis. 8, e2659. https://doi.org/10.1038/cddis.2017.53
- Ishikawa, Y., Nagai, J., Okada, Y., Sato, K., Yumoto, R., and Takano, M. (2010). Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells. Biol. Pharm. Bull. 33, 504-511. https://doi.org/10.1248/bpb.33.504
- Jensen, N.F., Stenvang, J., Beck, M.K., Hanakova, B., Belling, K.C., Do, K.N., Viuff, B., Nygard, S.B., Gupta, R., Rasmussen, M.H., et al. (2015). Establishment and characterization of models of chemotherapy resistance in colorectal cancer: towards a predictive signature of chemoresistance. Mol. Oncol. 9, 1169-1185. https://doi.org/10.1016/j.molonc.2015.02.008
- Jo, D.H., Lee, K., Kim, J.H., Jun, H.O., Kim, Y., Cho, Y.L., Yu, Y.S., Min, J.K., and Kim, J.H. (2017). L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma. Oncotarget 8, 15441-15452. https://doi.org/10.18632/oncotarget.14487
- Jo, D.H., Son, D., Na, Y., Jang, M., Choi, J.H., Kim, J.H., Yu, Y.S., Seok, S.H., and Kim, J.H. (2013). Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs. Mol. Cancer 12, 71. https://doi.org/10.1186/1476-4598-12-71
- Kaliki, S. and Shields, C.L. (2015). Retinoblastoma: achieving new standards with methods of chemotherapy. Indian J. Ophthalmol. 63, 103-109. https://doi.org/10.4103/0301-4738.154369
- Kaplan, H.J., Chiang, C.W., Chen, J., and Song, S.K. (2010). Vitreous volume of the mouse measured by quantitative high-resolution MRI. Invest. Ophthalmol. Vis. Sci. 51, 4414.
- Katano, K., Safaei, R., Samimi, G., Holzer, A., Rochdi, M., and Howell, S.B. (2003). The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol. Pharmacol. 64, 466-473. https://doi.org/10.1124/mol.64.2.466
- Katsetos, C.D., Herman, M.M., Frankfurter, A., Uffer, S., Perentes, E., and Rubinstein, L.J. (1991). Neuron-associated class III beta-tubulin isotype, microtubule-associated protein 2, and synaptophysin in human retinoblastomas in situ. Further immunohistochemical observations on the Flexner-Wintersteiner rosettes. Lab. Invest. 64, 45-54.
- Khokhlova, O.N., Tukhovskaya, E.A., Kravchenko, I.N., Sadovnikova, E.S., Pakhomova, I.A., Kalabina, E.A., Lobanov, A.V., Shaykhutdinova, E.R., Ismailova, A.M., and Murashev, A.N. (2017). Using tiletamine-zolazepamxylazine anesthesia compared to CO2-inhalation for terminal clinical chemistry, hematology, and coagulation analysis in mice. J. Pharmacol. Toxicol. Methods 84, 11-19. https://doi.org/10.1016/j.vascn.2016.10.005
- Kim, J.H., Kim, J.H., Yu, Y.S., Kim, D.H., Kim, C.J., and Kim, K.W. (2007). Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int. J. Oncol. 31, 585-592.
- Laurie, N., Mohan, A., McEvoy, J., Reed, D., Zhang, J., Schweers, B., Ajioka, I., Valentine, V., Johnson, D., Ellison, D., et al. (2009). Changes in retinoblastoma cell adhesion associated with optic nerve invasion. Mol. Cell. Biol. 29, 6268-6282. https://doi.org/10.1128/MCB.00374-09
- Laurie, N.A., Gray, J.K., Zhang, J., Leggas, M., Relling, M., Egorin, M., Stewart, C., and Dyer, M.A. (2005). Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin. Cancer Res. 11, 7569-7578. https://doi.org/10.1158/1078-0432.CCR-05-0849
- Longley, D.B. and Johnston, P.G. (2005). Molecular mechanisms of drug resistance. J. Pathol. 205, 275-292. https://doi.org/10.1002/path.1706
- Safaei, R. and Howell, S.B. (2005). Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit. Rev. Oncol. Hematol. 53, 13-23. https://doi.org/10.1016/j.critrevonc.2004.09.007
- Samimi, G., Safaei, R., Katano, K., Holzer, A.K., Rochdi, M., Tomioka, M., Goodman, M., and Howell, S.B. (2004). Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 10, 4661-4669. https://doi.org/10.1158/1078-0432.CCR-04-0137
- Stephan, H., Boeloeni, R., Eggert, A., Bornfeld, N., and Schueler, A. (2008). Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Invest. Ophthalmol. Vis. Sci. 49, 3158-3163. https://doi.org/10.1167/iovs.07-1016
- Torbidoni, A.V., Laurent, V.E., Sampor, C., Ottaviani, D., Vazquez, V., Gabri, M.R., Rossi, J., de Davila, M.T., Alonso, C., Alonso, D.F., et al. (2015). Association of cone-rod homeobox transcription factor messenger RNA with pediatric metastatic retinoblastoma. JAMA Ophthalmol. 133, 805-812. https://doi.org/10.1001/jamaophthalmol.2015.0900
- Wang, C., Guo, L.B., Ma, J.Y., Li, Y.M., and Liu, H.M. (2013). Establishment and characterization of a paclitaxelresistant human esophageal carcinoma cell line. Int. J. Oncol. 43, 1607-1617. https://doi.org/10.3892/ijo.2013.2083
- Wang, Y.F., Kunda, P.E., Lin, J.W., Wang, H., Chen, X.M., Liu, Q.L., and Liu, T. (2013). Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells. Oncol. Rep. 29, 1841-1850. https://doi.org/10.3892/or.2013.2315
- Wen, J., Zheng, B., Hu, Y., Zhang, X., Yang, H., Luo, K.J., Zhang, X., Li, Y.F., and Fu, J.H. (2009). Establishment and biological analysis of the EC109/ CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Oncol. Rep. 22, 65-71.
- Wu, C.P. and Ambudkar, S.V. (2014). The pharmacological impact of ATPbinding cassette drug transporters on vemurafenib-based therapy. Acta Pharm. Sin. B 4, 105-111. https://doi.org/10.1016/j.apsb.2013.12.001
- Yano, S., Miwa, S., Mii, S., Hiroshima, Y., Uehara, F., Yamamoto, M., Kishimoto, H., Tazawa, H., Bouvet, M., Fujiwara, T., et al. (2014). Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging. Cell Cycle 13, 953-960. https://doi.org/10.4161/cc.27818
- Zhu, X., Xue, L., Yao, Y., Wang, K., Tan, C., Zhuang, M., Zhou, F., and Zhu, L. (2018). The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells. Acta Biochim. Biophys. Sin. (Shanghai) 50, 914-920. https://doi.org/10.1093/abbs/gmy080